Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine

Neurology

Volumn 84, Issue 7, 2015, Pages 688-695

  Lipton, Richard B ^a,b   Fanning, Kristina M ^c   Serrano, Daniel ^a,c   Reed, Michael L ^c   Cady, Roger ^d   Buse, Dawn C ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c VEDANTA RESEARCH   (United States)

^d HEADACHE CARE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; EPISODIC MIGRAINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE TREATMENT OPTIMIZATION QUESTIONNAIRE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK; TRANSFORMED MIGRAINE; TREATMENT OUTCOME; TREATMENT RESPONSE; CHRONIC DISEASE; DISEASE COURSE; LONGITUDINAL STUDY; MIDDLE AGED; MIGRAINE DISORDERS; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; SOCIOECONOMICS; STATISTICAL MODEL; UNITED STATES;

CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; UNITED STATES;

EID: 84923239927     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001256     Document Type: Article

References (22)

1. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population based study. Headache 2008;48:1157-1168.
2. Lipton RB, Sollars MS, Buse DC. Migraine: epidemiology, progression, prognosis and comorbidity of migraine. In: Grosberg BM, Robbins M, Lipton RB, eds. Principles of Headache. New York: Wiley-Blackwell; 2013:64-87.
3. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000;123:1703-1709.
4. Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. J Clin Neurol 2012;89:89-99.
5. Lipton RB, Kolodner K, Bigal ME, et al. Validity and reliability of the migraine-treatment optimization questionnaire. Cephalalgia 2009;29:751-759.
6. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-349.
7. Buse DC, Manack AN, Fanning K, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 2012;52:1456-1470.
8. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004;24 (suppl 1):9-160.
9. Lipton RB, Diamond S, Diamond M, Reed M, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001; 41:638-645.
10. Liebenstein M, Bigal M, Sheftell F, Tepper S, Rapoport A, Lipton R. Validation of the Chronic Daily Headache Questionnaire (CDH-Q). Headache 2007;47: 760-761.
11. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629-808.
12. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996;47:871-875.
13. Silberstein SD, Lipton RB, Dodick DW. Operational diagnostic criteria for chronic migraine: expert opinion. Headache 2014;54:1258-1266.
14. Lipton RB, Manack AN, Serrano D, Buse DC. Acute treatment optimization for migraine: results of the American Migraine Prevalence & Prevention (AMPP) Study. Headache 2012;52:873.
15. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 1999;19:107-114.
16. Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol 2008;63: 148-158.
17. Bigal ME, Ashina S, Burstein R, et al. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 2008;70:1525-1533.
18. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press; 2000.
20. Abramson LY, Seligman ME, Teasdale JD. Learned helplessness in humans: critique and reformulation. J Abnorm Psychol 1978;87:49-74.
21. Heath RL, Saliba M, Mahmassani O, et al. Locus of control moderates the relationship between headache pain and depression. J Headache Pain 2008;9:301-308.
22. French DJ, Holroyd KA, Pinell C, Malinoski PT, O'Donnell F, Hill KR. Perceived self-efficacy and headache-related disability. Headache 2000;40:647-656.